January 19-20, 2018
Boca Raton Resort and Club,
A Waldorf Astoria Resort

501 East Camino Real
Boca Raton, FL 33432

Only practicing US and Canadian interventional cardiologists are eligible to participate.
There is no cost to apply.

Supported through educational grants from: MAJOR BENEFACTORS
Abbott, ABIOMED, Inc., Boston Scientific Corporation BENEFACTORS
Asahi Intecc USA, Inc., Cardiovascular Systems, Inc., Getinge Group, and Medtronic

Overview

This program is geared toward the interventionalist seeking to increase their knowledge on heart failure treatment, evaluation, and revascularization. In addition, participants will learn how to manage challenging patient subsets, such as high risk CTO patients and depressed LVEF, as well as how to provide optimal hemodynamic support. The use of simulator training will enhance the learning experience for interventionalists and fellows. Expert faculty will offer insights into selecting devices and patients, optimizing technique, and overcoming difficult anatomy. The latest clinical data and guidelines for complex, higher-risk procedures also will be reviewed. Case-based presentations with audience participation will be used to reinforce the latest treatment for patients undergoing CTO. Expert presenters will share techniques and treatments to improve patient care.

Learning Objectives

By the end of this program, participants
will be able to:

  • Explain the role and importance of complete revascularization
  • Apply new techniques and knowledge of device selection in managing patients
  • Identify the benefits of developing a CHIP protected PCI program
  • Discuss the different cases in which advanced techniques will benefit the patients
This educational activity is designed for practicing US and Canadian interventional cardiologists and clinical cardiologists involved in the management of patients with cardiovascular disease requiring hemodynamic support.
Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.


Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation, nor the course directors of this activity.


Faculty participating in medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.

This program is sponsored by the Cardiovascular Research Foundation. The Cardiovascular Research Foundation gratefully acknowledges the following supporters for this program:

MAJOR BENEFACTORS
Abbott
Abiomed, Inc.
Boston Scientific Corporation

BENEFACTORS
Asahi Intecc USA, Inc.
Cardiovascular Systems, Inc.
Getinge Group
Medtronic

The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience.

Only practicing US and Canadian interventional cardiologists are eligible to participate. Travel and hotel support will be provided to accepted applicants who fully participate in the program per the acceptance guidelines. There is no cost to apply. This program is not CME accredited.

This activity is not CME accredited, and therefore, the supporter is required under the Sunshine Act (as part of the Affordable Care Act) to track and report all payments and transfers of value to US licensed physicians, including meals and expenses that are provided to you. In order to help supporters comply with the Sunshine Act, the names and contact information of all US and Canadian licensed physicians participating in this function will be provided to the supporter of this program. The information provided will be used for reporting purposes only.


Should you partake in this program, you will be reported as part of the Sunshine Act submission and will appear on the CMS Open Payments website on the next reporting cycle.


VERMONT-LICENSED HCPs

Vermont laws prohibit this program from providing any complimentary food, meals, or refreshments to healthcare professionals licensed by and regularly practicing in Vermont. Accordingly, healthcare professionals licensed by and practicing in Vermont are requested not to apply for this program.

CHIP: Higher-Risk (and Indicated) Patients - Case-Based Approaches

Faculty

Coming Soon.

Agenda

Coming Soon.

APPLY

There is no cost to apply.

Should you have any questions, please contact Ryo Mochido at chip@crf.org.

Apply TODAY